Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1722 Pine St
Suite 309
Montgomery, AL 36106Phone+1 334-262-0342Fax+1 334-262-0390
Education & Training
Physicians Medical Center CarrawayResidency, Internal Medicine, 1983 - 1986
University of Alabama School of MedicineClass of 1983
Certifications & Licensure
AL State Medical License 1984 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Diabetes Recognition Program National Committee for Quality Assurance, 2013-2016
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 28 citationsAn Allosteric Modulator of α7 Nicotinic Receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N′-(5-methyl-3-isoxazolyl)-urea (PNU-120596), Causes Conformational Changes in the ...Sean C. Barron, James T. McLaughlin, Jennifer A. See, Vanessa L. Richards, Robert L. Rosenberg
Molecular Pharmacology. 2009-08-01 - 7 citationsAlternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises.Karen J. Loechner, James T. McLaughlin, Ali S. Calikoglu
International Journal of Pediatric Endocrinology. 2010-06-08 - 11 citationsConformational changes in α7 acetylcholine receptors underlying allosteric modulation by divalent cationsJames T. McLaughlin, Sean C. Barron, Jennifer A. See, Robert L. Rosenberg
BMC Pharmacology. 2009-01-13
Grant Support
- Agonist-Driven Conformational Changes In NachrsNational Institute On Drug Abuse2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
